In insulin-naïve patients with type 2 diabetes, glargine treatment combined with OADs is associated with significantly lower HbA1c levels and fewer episodes of symptomatic hypoglycaemia compared with premix [13]. Here, INS is linked to type 2 diabetes mellitus.